mRNA |
AA-COCF3 |
CTRPv2 |
pan-cancer |
AAC |
0.08 |
0.02 |
mRNA |
YL54 |
CTRPv2 |
pan-cancer |
AAC |
0.086 |
0.02 |
mRNA |
decitabine |
CTRPv2 |
pan-cancer |
AAC |
0.061 |
0.02 |
mRNA |
ruxolitinib |
CTRPv2 |
pan-cancer |
AAC |
-0.076 |
0.03 |
mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.07 |
0.03 |
mRNA |
GSK1059615 |
CTRPv2 |
pan-cancer |
AAC |
0.094 |
0.04 |
mRNA |
ZSTK474 |
CTRPv2 |
pan-cancer |
AAC |
0.076 |
0.04 |
mRNA |
PL-DI |
CTRPv2 |
pan-cancer |
AAC |
0.064 |
0.04 |
mRNA |
selumetinib:decitabine (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.068 |
0.04 |
mRNA |
SU11274 |
CTRPv2 |
pan-cancer |
AAC |
0.071 |
0.04 |